Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Intermittent Screening and Treatment (IST) or Intermittent Preventive Treatment (IPT) With Dihydroartemisinin-Piperaquine, Versus IPT With Sulfadoxine-Pyrimethamine for the Control of Malaria in Pregnancy in Kenya: a Randomized Controlled Trial

NCT01669941 is registered in ClinicalTrials.gov with Kenya Medical Research Institute as lead sponsor.

NCT NCT01669941
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01669941 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Intermittent Screening and Treatment (IST) or Intermittent Preventive Treatment (IPT) With Dihydroartemisinin-Piperaquine, Versus IPT With Sulfadoxine-Pyrimethamine for the Control of Malaria in Pregnancy in Kenya: a Randomized Controlled Trial
Lead sponsor
Kenya Medical Research Institute
Phase
Phase 4
Overall status
Completed
Start date
August 31, 2012
Completion date
December 31, 2015
Enrollment
1,546 (actual)
Sites
4

Conditions

As the registry lists them; a condition with its own page is linked.

malaria, pregnancy